chr9-26905635-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001031689.3(PLAA):āc.2264A>Gā(p.Asp755Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00251 in 1,614,184 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001031689.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLAA | NM_001031689.3 | c.2264A>G | p.Asp755Gly | missense_variant | 14/14 | ENST00000397292.8 | |
PLAA | NM_001321546.2 | c.2195A>G | p.Asp732Gly | missense_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLAA | ENST00000397292.8 | c.2264A>G | p.Asp755Gly | missense_variant | 14/14 | 1 | NM_001031689.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00187 AC: 284AN: 152248Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00173 AC: 435AN: 251398Hom.: 0 AF XY: 0.00170 AC XY: 231AN XY: 135868
GnomAD4 exome AF: 0.00258 AC: 3775AN: 1461818Hom.: 8 Cov.: 31 AF XY: 0.00250 AC XY: 1816AN XY: 727204
GnomAD4 genome AF: 0.00186 AC: 284AN: 152366Hom.: 1 Cov.: 32 AF XY: 0.00185 AC XY: 138AN XY: 74506
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Myelin Disorders Clinic-Children's Medical Center/Medical Genetics Lab-Tarbiat Modares University, Children's Medical Center, Pediatrics Center of Excellence, | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Human Genetics Department, Tarbiat Modares University | - | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 22, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | PLAA: BS2 - |
PLAA-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at